PSMA+ Extracellular Vesicles are a Biomarker for SABR in Oligorecurrent Prostate Cancer Analysis from the STOMP-like and ...
ORIOLE and STOMP are the two seminal randomized phase II trials in oligometastatic castration-sensitive prostate cancer (omCSPC) that have set the stage for metastasis-directed SBRT.1,2 Both trials included patients with ≤ 3 metachronous metastases and …